Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osi…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osi…
この記事を読む
Primary Spontaneous Pneumothorax (Clinical Decisions) Smyth R et al.N Engl J Med 2024;390:666-668 症例提示30歳の男性が、急な右側胸部痛と軽度…
この記事を読む
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Eff…
この記事を読む
Rheumatoid Arthritis and Risk of Lung Cancer: A Nationwide Cohort Study. Cho MH et al.J Thorac Oncol. 2024 Feb;19(2…
この記事を読む
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy…
この記事を読む
Surgical Resection of Benign Nodules in Lung Cancer Screening: Incidence and Features. Archer JM et al.JTO Clin Res Rep.…
この記事を読む
Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Funct…
この記事を読む
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Dise…
この記事を読む
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung c…
この記事を読む
Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamou…